Article 141: Correcting the Public CRO Market

• Despite strong revenue and operating profit grown, CRO market valuations are down significantly
• Analysts view a market correction as a sign that the industry is maturing. As a result, competition between CROs for contract clinical services is expected to intensify.

Article 142: Study Staff Face New Beasts of Burden

• CenterWatch editorial examines several initiatives -- Financial disclosure requirements, cross indemnification and investigator certification -- that threaten to place additional liability and responsibility pressure on investigative sites.

Article 143: CentreStage Europe: A Look at SMO usage in Continental Europe

Article 144: Eye On: Multiple Sclerosis

• CenterWatch analysts identify and review 21 drugs in clinical testing along with nine more soon to enter early stage clinical trials for the treatment of multiple sclerosis.